{"name": "Genalyte",
 "permalink": "genalyte",
 "crunchbase_url": "http://www.crunchbase.com/company/genalyte",
 "homepage_url": "http://www.genalyte.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "genalyte",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2007,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "sales@genalyte.com",
 "phone_number": "858.259.4363",
 "description": "",
 "created_at": "Tue Apr 03 03:30:08 UTC 2012",
 "updated_at": "Sat Apr 06 05:35:58 UTC 2013",
 "overview": "\u003Cp\u003EGenalyte, Inc., a San Diego, CA-based life sciences company developing and commercializing innovative next-generation multiplexing technology. Founded in 2007 and led by CEO and founder Cary Gunn, Genalyte has developed a new approach to immunodetection using silicon chip manufacturing methods. Its Maverick platform uses a technology called silicon photonics to directly measure protein binding between antibodies and antigens or hybridization of nucleic acids.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       37],
      "assets/images/resized/0018/2335/182335v1-max-150x150.png"],
     [[250,
       62],
      "assets/images/resized/0018/2335/182335v1-max-250x250.png"],
     [[284,
       71],
      "assets/images/resized/0018/2335/182335v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "Cary",
      "last_name": "Gunn",
      "permalink": "cary-gunn",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$11.8M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://www.finsmes.com/2012/03/genalyte-completed-11-8m-series-financing.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "Genalyte Completed $11.8M Series B Financing",
    "raised_amount": 11800000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 3,
    "funded_day": 30,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Claremont Creek Ventures",
         "permalink": "claremont-creek-ventures",
         "image":
          {"available_sizes":
            [[[150,
               36],
              "assets/images/resized/0002/3425/23425v2-max-150x150.jpg"],
             [[250,
               60],
              "assets/images/resized/0002/3425/23425v2-max-250x250.jpg"],
             [[364,
               88],
              "assets/images/resized/0002/3425/23425v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "3030 Bunker Hill St",
    "address2": "",
    "zip_code": "92109",
    "city": "San Diego",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}